199 related articles for article (PubMed ID: 10908271)
1. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension.
Abrams D; Schulze-Neick I; Magee AG
Heart; 2000 Aug; 84(2):E4. PubMed ID: 10908271
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil treatment of primary pulmonary hypertension.
Laupland KB; Helmersen D; Zygun DA; Viner SM
Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil as a treatment for pulmonary hypertension.
Carroll WD; Dhillon R
Arch Dis Child; 2003 Sep; 88(9):827-8. PubMed ID: 12937112
[TBL] [Abstract][Full Text] [Related]
4. Marked improvement with sildenafil in a patient with primary pulmonary hypertension unresponsive to epoprostenol.
Kataoka M; Satoh T; Manabe T; Anzai T; Yoshikawa T; Mitamura H; Ogawa S
Intern Med; 2004 Oct; 43(10):945-50. PubMed ID: 15575245
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease.
Kuroda T; Hirota H; Masaki M; Sugiyama S; Oshima Y; Terai K; Ito A; Yamauchi-Takihara K
Heart Lung Circ; 2006 Apr; 15(2):139-42. PubMed ID: 16574537
[TBL] [Abstract][Full Text] [Related]
6. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil in the management of primary pulmonary hypertension.
Singh B; Gupta R; Punj V; Ghose T; Sapra R; Grover DN; Kaul U
Indian Heart J; 2002; 54(3):297-300. PubMed ID: 12216929
[TBL] [Abstract][Full Text] [Related]
8. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
Humbert M
Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
[No Abstract] [Full Text] [Related]
9. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
[No Abstract] [Full Text] [Related]
10. Treatment of rebound pulmonary hypertension: why not sildenafil?
Raja SG
Anesthesiology; 2004 Dec; 101(6):1480; author reply 1481. PubMed ID: 15564966
[No Abstract] [Full Text] [Related]
11. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
[TBL] [Abstract][Full Text] [Related]
12. [Sildenafil in the treatment of pulmonary hypertension].
García Martínez E; Ibarra de la Rosa I; Pérez Navero JL; Tejero Mateo I; Expósito Montes JF; Suárez de Lezo y Cruz Conde J
An Pediatr (Barc); 2003 Jul; 59(1):110-3. PubMed ID: 12887879
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase inhibitors in the management of primary pulmonary hypertension.
Jue VI
Prog Cardiovasc Nurs; 2004; 19(2):74-9. PubMed ID: 15133384
[No Abstract] [Full Text] [Related]
14. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
[TBL] [Abstract][Full Text] [Related]
15. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.
Sastry BK; Narasimhan C; Reddy NK; Raju BS
J Am Coll Cardiol; 2004 Apr; 43(7):1149-53. PubMed ID: 15063421
[TBL] [Abstract][Full Text] [Related]
17. Marked improvement with sildenafil in a patient with idiopathic pulmonary arterial hypertension unresponsive to beraprost and sarpogrelate.
Kawano H; Sengyoku H; Satoh O; Urabe S; Koide Y; Yano K
Intern Med; 2007; 46(12):893-8. PubMed ID: 17575385
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
Ghofrani HA; Wiedemann R; Rose F; Schermuly RT; Olschewski H; Weissmann N; Gunther A; Walmrath D; Seeger W; Grimminger F
Lancet; 2002 Sep; 360(9337):895-900. PubMed ID: 12354470
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approaches to pulmonary hypertension in hemoglobinopathies: Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy.
Derchi G; Forni GL
Ann N Y Acad Sci; 2005; 1054():471-5. PubMed ID: 16339700
[TBL] [Abstract][Full Text] [Related]
20. [Hopes and experiences in the treatment of severe pulmonary hypertension].
Monserrat L; Penas Lado M; Castro-Beiras A
Rev Esp Cardiol; 2003 Mar; 56(3):228-9. PubMed ID: 12622951
[No Abstract] [Full Text] [Related]
[Next] [New Search]
